Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference30 articles.
1. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease;Barnes;J. Allergy Clin. Immunol.,2016
2. Effect of adenosine A2A receptor activation in murine models of respiratory disorders;Bonneau;Am. J. Physiol. Lung Cell Mol. Physiol.,2006
3. New insights into the immunology of chronic obstructive pulmonary disease;Brusselle;Lancet,2011
4. The Th17/Treg Cytokine Imbalance in Chronic Obstructive Pulmonary Disease Exacerbation in an Animal Model of Cigarette Smoke Exposure and Lipopolysaccharide Challenge Association;Cervilha;Sci. Rep.,2019
5. Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease;Eppert;J. Immunol.,2013
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A systematical strategy for quality markers screening of different methods processing Platycodonis radix based on phytochemical analysis and the impact on Chronic Obstructive Pulmonary Disease;Journal of Ethnopharmacology;2024-01
2. Ambient particulate matter (PM2.5) exposure contributes to neurodegeneration through the microbiome-gut-brain axis: Therapeutic role of melatonin;Environmental Toxicology and Pharmacology;2023-08
3. Differentiation in TCM patterns of chronic obstructive pulmonary disease by comprehensive metabolomic and lipidomic characterization;Frontiers in Immunology;2023-07-10
4. Astragaloside IV restores Th17/Treg balance via inhibiting CXCR4 to improve chronic obstructive pulmonary disease;Immunopharmacology and Immunotoxicology;2023-07-07
5. Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression;International Journal of Chronic Obstructive Pulmonary Disease;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3